Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Outcome Prediction
100%
Prostate Carcinoma
100%
Dimensionality Reduction
100%
CT Severity Score
100%
Reduction Approach
100%
Prostate-specific Membrane Antigen Positron Emission Tomography
100%
Radiomics
100%
CT Radiomics
100%
Metastasis-free Survival
80%
Metastasis
40%
Primary Tumor
40%
Clinical Factors
40%
Clinical Variables
40%
Feature Selection
40%
Principal Coordinate Analysis (PCoA)
40%
Reduction Method
40%
Gross Tumor Volume
40%
Train Set
40%
Prostate Cancer
20%
Nodal Involvement
20%
Clinical Data
20%
Computed Tomography
20%
External Beam Radiotherapy
20%
Prognostic Model
20%
Gleason Score
20%
PET Scan
20%
Survival Prediction
20%
Potential Biomarkers
20%
Androgen Deprivation Therapy
20%
Personalized Therapy
20%
Training Data
20%
High Performance
20%
Primary Tumor Volume
20%
Peritumoral
20%
Binary Classification
20%
Nodal Regions
20%
Nodal Volume
20%
Peritumoral Region
20%
Multi-regional
20%
Combined Tumor
20%
PSA Relapse
20%
Supervised Feature Selection
20%
Unsupervised Feature Selection
20%
Test Classification
20%
Imbalance Correction
20%
Multivariate Cox Regression
20%
Univariate Cox Regression
20%
Survival Test
20%
Weighted Averaging
20%
Data Imbalance
20%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Prostate Adenocarcinoma
100%
Prostate Specific Membrane Antigen
100%
Radiomics
100%
Metastasis Free Survival
50%
Area under the Curve
50%
Neoplasm
37%
Primary Tumor
37%
Feature Extraction
37%
Proportional Hazards Model
25%
Principal Component Analysis
25%
Biological Marker
12%
External Beam Radiotherapy
12%
Prostate Cancer
12%
Gleason Score
12%
Personalized Medicine
12%
positron emission tomographic scan
12%
Androgen Deprivation Therapy
12%
Survival Prediction
12%
X-Ray Computed Tomography
12%
Prognostic Model
12%
Pharmacology, Toxicology and Pharmaceutical Science
Polyethylene Terephthalate
100%
Prostate Adenocarcinoma
100%
Prostate Specific Membrane Antigen
100%
Metastasis Free Survival
100%
Neoplasm
75%
Primary Tumor
75%
Prostate Cancer
25%
Biological Marker
25%
Gleason Score
25%
Androgen
25%
Survival Prediction
25%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
Prostate Specific Membrane Antigen
100%
Metastasis Free Survival
100%
Pretreatment
100%
Feature Extraction
75%
Gross Tumor Volume
50%
Gleason Score
25%
positron emission tomographic scan
25%
X-Ray Computed Tomography
25%
Survival Prediction
25%
Prognostic Model
25%